Pharmacological inhibition of NOX1 with GKT771 during HCC progression in mice attenuates the expression of several inflammatory markers, angiogenesis and fibrosis, therefore reducing the pro-tumorigenic environment [146]. This evidence concerns the gene NOX1 and hepatocellular carcinoma.